Ascletis Pharma (OTCMKTS:ASCLF – Free Report) and Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership. Analyst Recommendations This is a summary of current recommendations for […]
/PRNewswire/ Ascletis Pharma Inc. (HKEX:1672, "Ascletis") today announces the poster presentation of ASC42, a novel farnesoid X receptor (FXR) agonist, in.
Respiratory Syncytial Virus Clinical Trial Pipeline Insights | 50+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the China National Medical Products Administration ("NMPA") has approved to.
Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Rating) was the recipient of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 705,000 shares, a drop of 9.1% from the March 31st total of 776,000 shares. Based on an average trading volume of 200 shares, the […]